Cure - Pharmaceutical
Pharmaceutical
About
Management Team
Board of Directors
Scientific and Medical Team
Scientific Advisory Board
Science
Growth Pillars
Pipeline
Investors
Proprietary Benefits
Contact
Careers
Culture
Benefits
Job Opportunities
Contact
Toggle menu
Investors
Cure
>
Investors
PROPRIETARY BENEFITS
De-risked due to approved API and proven delivery system
Patent reinforcing to further
protect technology
Additional significant revenue from
exclusive manufacturing contracts
Interested parties may contact:
Mark Udell, Chief Financial Officer at
Mudell@curepharma.com